By using WellRx, you accept our Privacy Policy (including the CA Privacy Act policy if you are a CA resident), including our collection of data and use of cookies.
-
-
MENEST
- QTY 30
- 0.3 MG
- Tablet
- Near 85003
ESTERIFIED ESTROGENS (es TAIR i fyed ES troe jenz) relieves the symptoms of menopause, such as hot flashes or vaginal dryness. It may also be used to treat low estrogen levels. It is also used to reduce the symptoms of breast or prostate cancer. It works by increasing levels of the hormone estrogen in the body. This medication is an estrogen hormone.
Change Location
Set Price Drop Alert for:
MENEST
- QTY 30
- 0.3 MG
- Tablet
What does Supply mean?
If your selected quantity is intended to last longer than one month, please recheck the price using the 3-months supply option. In some cases, the estimated drug price may vary depending on the supply duration.
More Ways to Save On:
MENEST
- QTY 30
- 0.3 MG
- Tablet
You may find alternative ways to save with this medication. Talk to your pharmacist about the potential option(s) noted below.
Medicine Chest
MENEST Lifestyle Interactions
-
Iodixanol 652mg/1mL, Solution for injection
• Interaction: Caffeine-containing Foods/Beverages• Severity: Major• Notes for Consumers: Although Radiopaque Contrast Agents and Caffeine can interact, Radiopaque Contrast Agents are only used in a hospital or clinic during various imaging procedures. Sometimes, Radiopaque Contrast Agents (examples iohexol or Omnipaque or Iopamidol or Isovue) are injected into your spinal fluid through your back (called intrathecally). If you have a high intake of caffeinated beverages (like coffee, colas, or teas) and you receive Radiopaque Contrast Agents through your back, the risk of seizures could be increased. Discuss your caffeine intake with your health care provider prior to any procedures or exams.• Notes for Professionals: Use of medications that lower the seizure threshold should be carefully evaluated when considering intrathecal radiopaque contrast agents. Caffeine and caffeine containing products should be discontinued at least 48 hours before myelography and should not be resumed for at least 24 hours postprocedure.
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment. Drug information is sourced from GSDD (Gold Standard Drug Database ) provided by Elsevier.
